Skip to main content
OpenTrials

Clinical trial condition

Primary Hyperoxaluria

Explore clinical trials studying Primary Hyperoxaluria. Study availability and eligibility vary by location and protocol.

19 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Primary Hyperoxaluria trial results

Completed

A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria

NCT03116685

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +12 more
Locations
  • Vanderbilt University Hospital Nashville, Tennessee, United States
  • Centre Hospitalier Universitaire de Liège Liège, Belgium
  • Hôpital Robert Debré Paris, France
  • Kindernierenzentrum Bonn Bonn, Germany
View Trial Details
Completed

Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia

NCT03391804

Conditions
Calculi, Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +21 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • Applied Research Center of Arkansas Little Rock, Arkansas, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria

NCT02012985

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +12 more
Locations
  • Hôpital Robert-Debré, Néphrologie Pédiatrique Paris, Cedex 19, France
  • Hôpital des Enfants, Centre de référence maladies rénales rares du Sud-Ouest (SORARE), CHU de Bordeaux Bordeaux, France
  • Hôpital Femme Mère Enfant, Lyon - Paediatric Dept Lyon, France
  • Hôpital Necker-Enfants Malades,Centre de référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte (MARHEA) Paris, France
View Trial Details
Completed

Phase 2/3 Oxabact Study

NCT01037231

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +12 more
Locations
  • Mayo Clinic (Department of Pediatric Nephrology) Rochester, Minnesota, United States
  • University Children's Hospital (Division of Pediatric Nephrology) Cologne, Germany
  • Academy Medical Center, University of Amsterdam Amsterdam, Netherlands
View Trial Details

Related conditions